Assays for Human Tropomyosin Receptor Kinases Developed to Help Identify Inhibitors and Activators of Nerve Growth Factor Receptors State College, PA (January 3, 2023) – INDIGO Biosciences announced today the release of three new cell-based luciferase reporter assays for Human Tropomyosin Receptor Kinases TrkA (NTRK1), TrkB (NTRK2), and TrkC (NTRK3). TrkA, TrkB, and TrkC—also knownRead More
TGR5 (GPBAR1) Assay for Human G Protein-Coupled Bile Acid Receptor 1 Now Available
TGR5 Assay Offers Insight for Drug Discovery Related to Diabetes, Cholesterol Management, and Obesity State College, PA (November 29, 2022) – Today INDIGO Biosciences announced the release of a new cell-based luciferase reporter assay for the Human G Protein-Coupled Bile Acid Receptor 1 (GPBAR1; TGR5). TGR5 is a bile acid membrane receptor of the GPCRRead More
INDIGO Biosciences Receives Approval from California Water Boards for Use of Its Bioassays in Recycled Water Monitoring
INDIGO’s Aryl Hydrocarbon Receptor (AhR) and Estrogen Receptor Alpha (ERα) Bioassays Approved for Monitoring Constituents of Emerging Concern Per Recycled Water Policy State College, PA (November 7, 2022) – INDIGO Biosciences, Inc. has received approval from the California Water Boards, State Water Resources Control Board, for the use of two of its bioassays in recycledRead More
INDIGO Biosciences Releases Assay for Human Tumor Protein P53
Cell-Based P53 Reporter Assay Provides Insight for Pre-Clinical Cancer Drug Discovery State College, PA (September 27, 2022) – INDIGO Biosciences announced today the addition of a new cell-based luciferase reporter assay for Human Tumor Protein P53. The new assay is part of INDIGO’s portfolio of assays for cancer research. The bioscience company’s cell-based luciferase reporterRead More